Microsomia
Description | (appropriate length-for-age below the 3rd percentile) Basic evaluations: Full blood count, ESR, sodium, potassium, calcium, chlorine, phosphorus, magnesium, creatinine, GOT, GPT, AP, urine status Screening: Growth hormone, IGF-1, IGFBP-3 (IGFBP-3 as a screening test to detect STH-deficiency is probably superior to IGF-1 test), growth hormone before and after physical exertion, GH-RH stimulation test, arginine stimulation test, clonidine-STH-stimulation test (please refer to relevant function test) Tests for etiological evaluation: LH, FSH, testosterone, estradiol, TSH, FT3, FT4, 17-hydroxyprogesterone (on suspicion of adrenogenital syndrome), cortisol, HbA1c, gliadin- and endomysium antibodies (Celiac: also consider non-classical form of Celiac/sprue, see there), folic acid, chromosome analysis in girls Please also refer to section “pubertas tarda”
|
More Results for the letter M
- Miller-Fisher-syndrome
- Missed abortion
- MOGAD (MOG-Antibodies-associated disease)
- Monoclonal gammopathy
- Monocytosis (> 800 µl)
- Morbus hemolyticus neonatorum / Hemolytic disease of the newborn
- Movement disorders
- Mucopolysaccharidosis
- Mucoviscidosis
- Multiple chemical sensitivity (MCS)
- Multiple endocrine neoplasia type 1 (MEN 1)
- Multiple endocrine neoplasia type 2A and 2B (MEN 2A and MEN 2B)
- Multiple myeloma (plasmocytoma) and Waldenstöm’s disease
- Multiple Sclerosis
- Muscle atrophy, spinal and spinobulbar
- Muscle dystrophy type Becker (BMD) and Duchenne (DMD)
- Muscle spasms /cramps
- Muscle weakness / myasthenia
- Myalgia
- Myasthenia gravis
- Mycosis fungoides
- Myelitis
- Myelodysplastic syndrome (MDS)
- Myocardial infarction
- Myocarditis
- Myopathy (degenerative myopathy)
- Myositis (inflammatory myopathy)